Drug Type Small molecule drug |
Synonyms 5-[(4S,5S)-5-(4fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzene-1,3-dicarbonitrile |
Target |
Mechanism D5D inhibitors(fatty acid desaturase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H12FN3O2 |
InChIKeyNJAIJURIMBUHLD-APPDUMDISA-N |
CAS Registry2138476-91-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | JP | 31 Oct 2017 |